Biotechnology and pharmaceutical scientists are increasingly relying on high-throughput screening (HTS) methods to discover new leads that may, in turn, be transformed into promising therapeutics. GEN ...

High-throughput screening (HTS) is crucial to generate hits and leads in drug discovery efforts. Most high-throughput biochemical assays are based on optical detection or radioactivity with high ...

Roche researchers have set out how patient-derived organoids, automation and high-content imaging have combined within the ...

Invitrogen ProcartaPlex and QuantiGene Plex assays offer the unique ability of a multi-omics high-throughput approach by utilizing the Luminex platform. Genomic and proteomic workflows can be combined ...

Recent advances in organoid technology have opened the possibility of revolutionizing basic research, drug discovery and development, and patient treatment. In drug discovery, organoids are a viable ...

Scientists often turn to high throughput screening (HTS) to quickly assay large-scale compound libraries against a desired target, accelerating life science research. New technologies and relevant ...

3D cell models offer a more physiologically relevant environment than traditional 2D cultures, making them a preferred option for modern drug discovery workflows. However, adapting high-throughput ...

Three-dimensional cancer cell models, like tumoroids and spheroids, closely mimic the structure and behavior of tumors, making them powerful tools in cancer research and drug development. However, ...

Creative BioMart is pleased to announce the upgrade of its protein deubiquitination assay service, providing researchers with a more sensitive, flexible, and high-throughput platform to study ...

Patient-derived organoids (PDOs), including those from tumors, are implemented as predictive models of patient responses to drugs and therapies. Incorporation of the BioAssembly ™ platform has been ...